Recent evidence suggests that this pathway also plays a role in ovarian cancer; NF-κB activation has been shown to increase the aggressiveness of ovarian cancer cell lines [2], and overexpression of the NF-κB subunit p50 has been shown to be positively correlated with poor outcome among ovarian cancer patients [3]. The gene discussed is NFKB1; the disease is ovarian carcinoma.